Atossa Genetics, Inc. (NASDAQ:ATOS) closed its last session at $0.72. The stock traded within a range of $0.600 and $0.720. The company operates in the Healthcare sector with a market capitalization of 23840. Trading volume for Atossa Genetics, Inc. was 7.25 Million in its previous trading session. Currently, Atossa Genetics, Inc. (NASDAQ:ATOS) has an average volume of 4.62 Million.
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company’s diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.
Atossa Genetics, Inc. (NASDAQ:ATOS) received a Buy rating from 1 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.
Atossa Genetics, Inc. (NASDAQ:ATOS) touched its 1-Year High price of $1.650 on 03/15/17 and its 1-Year Low price of $0.220 on 12/20/17.
EPS & Financials
For the current quarter, 0 analysts are projecting a mean EPS of $0/share. According to their observations and findings, the stock could provide a high EPS of $0/share and a low EPS of $0/share.
By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with MEDIUM volatility. Atossa Genetics, Inc. (NASDAQ:ATOS) has a 20-Day average volume of 11.56 Million. According to today’s trading volume Atossa Genetics, Inc. is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BEARISH trend as well.
The company currently has an insider ownership of 1.06 Percent and Institutional ownership of 10.1 Percent. The return on assets stands at -303.5%, Return on Equity currently is -449.2% and the Return on Investment value is 0%.
Atossa Genetics, Inc. (NASDAQ:ATOS) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 41.82% with a 50-Day Simple Moving Average of 93.05 percent. As of today, the company has a SMA200 (200-day simple moving average) of 60.97 Percent. The Stock has YTD (year to date) performance of 173.35 percent.
The TTM operating margin for the company stands at 0%. The return on invested capital is at 0%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.
The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 60.97%, and has a solid year to date (YTD) performance of 173.35% which means that the stock is constantly adding to its value from the previous fiscal year end price.